The past few years of market gains have been dominated by large-cap tech and AI darlings: stocks priced for perfection in an environment that may be about to turn less forgiving. With oil prices elevated, inflation proving stickier than expected, and the probability of Federal Reserve rate cuts falling sharply, investors who overpaid for growth are increasingly exposed. The antidote is value, meaning companies generating real cash, trading at single-digit forward multiples, and carrying the kind of operational resilience that holds up when macro conditions tighten.

To build this list, we screened for stocks with forward P/E ratios between 4 and 8, filtered for recent positive catalysts, and cross-referenced with AltIndex's proprietary AI scoring model. Out of dozens of candidates, only three cleared our AI score threshold of 60 with a confirmed buy signal: Lennar Corporation (LEN), Lithia Motors (LAD), and Viatris Inc. (VTRS). Here is the case for each.

And first, a gold + copper miner under $1:

For most of the past decade, gold was viewed as a hedge.

Now it's being repriced as a strategic asset.

Bank of America and JPMorgan have both lifted their gold targets toward $6,000 as central bank buying accelerates and fiscal uncertainty grows.

When that happens, capital usually flows first into bullion and large producers.

Smaller exploration names often follow later.

But one junior still trades under $1 with drilling underway in a district that has produced more than 30 million ounces of gold.

Why it stands out:

Wall Street has repriced many gold names.

Not this one.

Methodology: Stocks were identified using a forward P/E screen of 4–8x, filtered for significant hedge fund ownership and recent developments likely to affect investor sentiment. All three stocks were independently validated with an above average AltIndex AI Score - combining web traffic trends, hiring activity, social sentiment, insider activity, and alternative data signals not available in traditional financial screening.

Lennar is trading nearly 30% below its 52-week high, which is a significant dislocation for one of America's most important homebuilders. The company's Q1 2026 results disappointed on the surface: revenue from home sales fell 13% year-over-year to $6.3 billion, and EPS of $0.93 missed the consensus of $0.97. But it seems that the bear case is largely priced in. Lennar's balance sheet remains formidable, with $2.1 billion in cash and a debt-to-capital ratio below 15%. That’s a financial position that rivals almost any company in its peer group.

The more important story is structural. The US housing deficit stands at an estimated 4 million homes, and the so-called "lock-in effect" where homeowners sitting on 3% mortgages refuse to sell has effectively handed the new-build market to companies like Lennar by default. Every month that rates stay elevated is another month of deferred buying demand accumulating on the sideline.

Lennar's strategic transformation makes this a fundamentally different business than it was five years ago. The company completed its spin-off of Millrose Properties (a $5.5 billion land REIT), accelerating its transition to a pure-play, asset-light home manufacturer. Instead of tying capital up in years of land inventory, Lennar now accesses finished lots on a just-in-time basis, reducing balance sheet risk while preserving production volume. Direct construction costs fell 7% year-over-year in Q1, inventory turns improved to 2.5x from 1.7x a year ago, and the company is on track to deliver 85,000 homes in full-year 2026.

The near-term headwinds (tariffs on lumber and steel, immigration-related labor costs, and affordability-driven incentives) are real, but largely temporary. Meanwhile, policy tailwinds are building: a White House initiative to open federal land to private development, bipartisan zoning reform gaining momentum, and proposed first-time buyer grants could unlock a substantial wave of new demand.

Lithia Motors (operating under the brand "Lithia & Driveway") is the largest global automotive retailer, with 455 locations across the US, UK, and Canada and full-year 2025 revenue of $37.6 billion, a 4% year-over-year increase. The stock trades at roughly 8.9x normalized earnings, yet Morningstar's fair value estimate of $387 implies approximately 43% upside from current levels near $270. Simply Wall St's analysis puts the discount to intrinsic value at an even wider 58%.

What makes Lithia compelling as a value stock is not just the multiple compression… it's the quality of the earnings flywheel being built underneath it. The company's captive finance arm, Driveway Finance Corporation (DFC), scaled to a nearly $5 billion loan portfolio in 2025 and turned its first full profitable year, contributing $75 million (a $66 million year-over-year increase). Management has guided DFC toward $150–200 million in annual financing income as the portfolio matures, creating a high-margin recurring revenue stream that most auto retailers simply do not have. Aftersales gross profit grew 9.4% on a same-store basis in 2025, reinforcing that the recurring, high-margin segments of the business are accelerating.

Capital allocation has been aggressive and shareholder-friendly. Lithia repurchased 11.4% of its outstanding shares in 2025 at a weighted-average price significantly above current levels. This might be a signal that management views the current valuation as deeply discounted. The company also acquired $2.4 billion in annualized revenue through dealership additions, growing its network to within 200 miles of 95% of the US population.

International diversification adds another dimension. UK operations delivered a 10% increase in same-store gross profit and 53% growth in adjusted pretax income for the full year. Lithia is also investing in Pinewood AI and a proprietary dealer management system, two infrastructure plays that should drive workflow efficiency and margin expansion across the network over the coming years.

Viatris was born in 2020 from the merger of Mylan and Pfizer's off-patent Upjohn division, making for a complex, debt-heavy combination that the market treated as a value trap for years. That narrative has now decisively shifted. Under CEO Scott Smith's "Phase 2" strategy, Viatris has completed a multi-billion-dollar divestiture program, dramatically reduced its debt load, and repositioned itself as a specialty and high-barrier generic pharmaceutical company with a global presence in over 165 countries. The stock has returned approximately 16% over the past 3 months, but still trades at a forward P/E of roughly 5.5x.

The 2026 investment VTRS thesis rests on three pillars. First, the company is guiding for roughly 3% revenue growth to approximately $14.7 billion at the midpoint, with $450–550 million expected from new product launches. Second, Viatris has built a compelling ophthalmology franchise anchored by Ryzumvi and is now pursuing an expansion into presbyopia (age-related loss of near focusing ability in eyesight) with MR-141. That’s a phentolamine ophthalmic solution whose supplemental NDA has been accepted by the FDA with a PDUFA decision date of October 17, 2026. Presbyopia affects approximately 90% of US adults over 45, representing a large addressable market. Third, institutional ownership has risen to approximately 84%, with Vanguard and BlackRock both increasing positions. That’s a signal of growing confidence from large capital allocators in the Phase 2 transformation.

The free cash flow story is compelling. Viatris converted its earnings to cash at a high rate even during the restructuring years, and the reduced interest burden from debt paydown is now flowing directly to the bottom line. The EV/EBITDA ratio of approximately 6.5x remains well below pharmaceutical sector norms, and analysts at UBS and Barclays have noted the company is now "clean" of restructuring noise. The Biocon Biologics divestiture alone added $815 million in proceeds while unlocking full biosimilar commercialization rights.

All three stocks share a common profile: they are large, well-known businesses trading at depressed multiples due to sector-specific headwinds that are either temporary or already priced in. Lennar sits atop one of the most persistent structural supply deficits in modern American economic history. Lithia is quietly building a captive lending and digital platform that the market is not yet crediting at full value. Viatris has finished its long post-merger restructuring and is beginning to deliver on a specialty pipeline with real regulatory momentum.

In a market where paying 30x earnings for AI optionality has become the default, these three companies offer something rarer: a low entry price, a genuine operational catalyst, and an alternative data insight pointing to growth / high value.

Visit Best Undervalued Stocks to always stay updated in real-time on undervalued stocks.

Disclaimer: The information provided is for educational and informational purposes only and should not be construed as financial or investment advice. All investments involve risk, and you should conduct your own research or consult a qualified professional before making any investment decisions.

Your feedback matters to us! Let us know what you liked or didn’t like about today’s edition.

That’s all for today. Did we miss anything? Smash the reply button to let me know.

Cheers,
Brandon & Blake of Invested Inc